« Previous Next » American Journal of Kidney Diseases
Volume 43, Issue 4 , Pages 663-670 , April 2004

A double-blind, placebo-controlled trial of intravenous iron dextran therapy in patients with ESRD and restless legs syndrome

James A. Sloand, MD
- Department of Medicine, Nephrology Division, University of Rochester School of Medicine, Rochester, NY, USA
- Address reprint requests to James A. Sloand, MD, Nephrology Division, Highland Hospital, 1000 South Ave, Rochester, NY 14620 USA
Mark A. Shelly, MD
- Department of Medicine, Nephrology Division, University of Rochester School of Medicine, Rochester, NY, USA
- Department of Medicine, Infectious Disease Division, University of Rochester, Rochester, NY, USA
- Department of Neurology, Movement Disorder Center, North Shore-Long Island Jewish Research Institute, New Hyde, NY, USA
Andrew Feigin, MD
- Department of Medicine, Nephrology Division, University of Rochester School of Medicine, Rochester, NY, USA
- Department of Medicine, Infectious Disease Division, University of Rochester, Rochester, NY, USA
- Department of Neurology, Movement Disorder Center, North Shore-Long Island Jewish Research Institute, New Hyde, NY, USA
Paul Bernstein, MD
- Department of Medicine, Nephrology Division, University of Rochester School of Medicine, Rochester, NY, USA
- Department of Medicine, Infectious Disease Division, University of Rochester, Rochester, NY, USA
- Department of Neurology, Movement Disorder Center, North Shore-Long Island Jewish Research Institute, New Hyde, NY, USA
Rebeca D. Monk, MD
- Department of Medicine, Nephrology Division, University of Rochester School of Medicine, Rochester, NY, USA
- Department of Medicine, Infectious Disease Division, University of Rochester, Rochester, NY, USA
- Department of Neurology, Movement Disorder Center, North Shore-Long Island Jewish Research Institute, New Hyde, NY, USA